IRIS
MATALUNI, GIORGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.501
AS - Asia 1.786
EU - Europa 1.534
SA - Sud America 246
AF - Africa 23
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.097
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.462
SG - Singapore 873
IT - Italia 585
CN - Cina 249
RU - Federazione Russa 216
BR - Brasile 208
KR - Corea 177
HK - Hong Kong 163
VN - Vietnam 148
IE - Irlanda 146
DE - Germania 120
GB - Regno Unito 95
UA - Ucraina 92
FR - Francia 74
JP - Giappone 55
NL - Olanda 54
FI - Finlandia 35
IN - India 30
CA - Canada 24
SE - Svezia 22
AT - Austria 19
BD - Bangladesh 15
TR - Turchia 15
CH - Svizzera 14
IQ - Iraq 14
AR - Argentina 13
RO - Romania 11
ZA - Sudafrica 11
ES - Italia 10
PL - Polonia 10
CL - Cile 6
CO - Colombia 6
ID - Indonesia 6
KG - Kirghizistan 5
MX - Messico 5
PK - Pakistan 5
PY - Paraguay 5
UZ - Uzbekistan 5
BE - Belgio 4
CZ - Repubblica Ceca 4
LU - Lussemburgo 4
MY - Malesia 4
PH - Filippine 4
TT - Trinidad e Tobago 4
AL - Albania 3
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
IR - Iran 3
PE - Perù 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BS - Bahamas 2
DZ - Algeria 2
EC - Ecuador 2
HR - Croazia 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
KZ - Kazakistan 1
LT - Lituania 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 12.097
Salva come PNG Salva come JPEG
Città #
Wilmington 2.269
Houston 1.988
Woodbridge 1.801
Singapore 485
Chandler 262
San Jose 191
Fairfield 176
Hong Kong 159
New York 144
Dublin 137
Ashburn 133
Ann Arbor 112
Beijing 97
Medford 86
Rome 84
Santa Clara 80
Cambridge 72
Seattle 70
The Dalles 55
Dearborn 54
Ho Chi Minh City 52
Los Angeles 52
Tokyo 49
Jacksonville 48
Milan 47
Lawrence 41
Moscow 40
Lauterbourg 38
Hanoi 37
Dallas 32
North Bergen 24
São Paulo 24
Buffalo 21
Council Bluffs 21
Redondo Beach 20
Turin 18
Piove di Sacco 17
Roebling 17
San Diego 17
Munich 15
Naples 15
Nuremberg 15
Palo Alto 14
Bologna 13
London 12
Seoul 12
Florence 10
Orem 10
Atlanta 9
Lappeenranta 9
Verona 9
Amsterdam 8
Creede 8
Helsinki 8
Redwood City 8
San Francisco 8
Vienna 8
Basingstoke 7
Haiphong 7
Istanbul 7
Manchester 7
Montreal 7
Salt Lake City 7
Warsaw 7
Chennai 6
Elk Grove Village 6
Lodi 6
Mülheim 6
Norwalk 6
Paris 6
Da Nang 5
Kilburn 5
Menlo Park 5
Palermo 5
Tooting 5
Vicenza 5
Ankara 4
Belo Horizonte 4
Bergamo 4
Boston 4
Brno 4
Chengdu 4
Chicago 4
Engelhard 4
Erbil 4
Frankfurt am Main 4
Guangzhou 4
Inverigo 4
Jakarta 4
Jinan 4
Johannesburg 4
Karbala 4
Kunming 4
Lausanne 4
Modena 4
Mountain View 4
Phoenix 4
Quảng Ngãi 4
San Lazzaro di Savena 4
Schio 4
Totale 9.472
Salva come PNG Salva come JPEG
Nome #
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 492
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 461
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 454
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 451
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 447
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 435
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 429
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 423
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 408
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 407
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 379
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 376
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 376
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 349
Motor unit number estimation in 30 patients with chronic dysimmune neuropathies 342
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 334
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 334
Regional variation of Guillain-Barré syndrome 317
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 317
Miscarriage induces reactivation of inflammation in relapsing-remitting multiple sclerosis 311
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 299
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 266
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 262
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND ANTI-CONTACTIN-ASSOCIATED PROTEIN-1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 251
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND CONTACTIN-ASSOCIATED PROTEIN 1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 243
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 200
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 180
Current treatment practice of Guillain-Barré syndrome 164
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 152
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 147
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 132
Assessment of macular function by multifocal electroretinogram in patients with multiple sclerosis treated with fingolimod 122
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 118
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 117
Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 110
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 105
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 101
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus 96
Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey 93
The neurophysiological lesson from the Italian CIDP database 86
null 81
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 79
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 77
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection 77
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 70
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 68
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 68
Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells' Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration 67
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 63
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 61
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 58
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis 56
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 53
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 53
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values 50
Structural and Functional Assessment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes Without History of Optic Neuropathy 49
Response to Dr. Wee 47
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy 47
Impact of environmental factors and physical activity on disability and quality of life in CIDP 47
High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial 42
null 3
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 1
Totale 12.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021120 0 0 0 0 0 0 0 0 0 36 62 22
2021/2022433 28 35 13 38 24 42 13 19 32 38 28 123
2022/2023851 53 58 100 125 59 159 89 38 79 5 62 24
2023/2024376 62 12 26 22 29 60 27 11 23 22 3 79
2024/20251.448 45 298 155 106 69 130 64 69 164 134 126 88
2025/20261.945 150 92 267 133 219 54 378 227 256 169 0 0
Totale 12.303